ViaCyte, Inc.

Return to Grants

Total Awards:
Award Value:
Institution type:
For profit
Short Name:

Awards to the Institution

Program Type Investigator Grant Title Award Value
Quest – Discovery Stage Research Projects Dr. Alan D. Agulnick Preclinical development of an immune evasive islet cell replacement therapy for type 1 diabetes $1,470,987
Clinical Trial Stage Projects Manasi Jaiman Clinical trial of directly vascularized islet cell replacement therapy for high-risk type 1 diabetes $13,607,002
Late Stage Preclinical Projects Dr. Tim Kieffer Stem cell-derived islet cell replacement therapy with immunosuppression for high-risk type 1 diabetes $3,544,721
Accelerated Development Pathway I Howard Foyt Clinical Development of a Cell Therapy for Diabetes $8,783,852
Disease Team Planning Dr. Emmanuel Edward Baetge Development of a Cell Replacement Therapy Product for Insulin Dependent Diabetes $48,950
Strategic Partnership I Howard Foyt Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes $9,475,070
Early Translational I Dr. Olivia G. Kelly Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product $5,405,397
Tools and Technologies I Dr. Evert Kroon Development of the Theracyte Cellular Encapsulation System for Delivery of human ES Cell-derived Pancreatic Islets and Progenitors. $827,072
Disease Team Research I Allan Robins Cell Therapy for Diabetes $0